Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitsar is a Russian neurodiagnostics and medical device company focused on electroencephalography, neurophysiology, and functional diagnostics. The company develops and commercializes EEG systems, video EEG monitoring systems, ambulatory EEG solutions, evoked potential systems, biofeedback tools, and brain-computer interface products for clinical and research use. Mitsar appears to operate primarily as an equipment manufacturer rather than a drug developer, with its products used in neurology, epilepsy monitoring, neurofeedback, and scientific brain research. The company has exported internationally for years and markets CE-marked EEG-related systems and associated software. For a biotech analyst, Mitsar is best understood as a commercial-stage neurotechnology/medical equipment company rather than a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mitsar.